The 13F filings for Q2 2025 dropped last week, and the metadata screams one thing: Jane Street went all-in on XRP ETFs. Their disclosed position in the Bitwise XRP ETF jumped from 20,605 shares to over 1.2 million โ a 58x increase in a single quarter. That is not a rounding error. That is a structural shift in how one of the world's largest market makers is positioning a digital asset that the broader market has been treating as a laggard.
But here is the rub. The filing is a backward-looking snapshot, frozen as of June 30, 2025. The market has already traded through the summer and into autumn. The price action since then shows XRP struggling to hold above $0.50, far from its 2024 highs. Data doesn't care about your timeline. The 13F data is a record of what happened, not a prediction of what will happen. Yet the narrative machine is already spinning: 'Institutions are flooding into XRP.' Let me walk through the on-chain evidence chain and separate the signal from the ambient noise.
Context: The 13F Filing Landscape
Form 13F is the SEC's window into the portfolios of institutional investment managers with over $100 million in assets under management. Every quarter, these filings offer a delayed but verifiable snapshot of the smart money's moves. The Q2 2025 filings, due in August, revealed a handful of new positions in XRP-focused ETFs โ Bitwise, Canary, Grayscale, and Volatility Shares. The standout was the Bitwise XRP ETF, which directly holds spot XRP, as confirmed by the prospectus. Jane Street's stake was the largest single position, but other names appeared: Wolverine Asset Management, Gallacher Capital, Bank of America, and Morgan Stanley.
Core: The Evidence Chain
Let me quantify the anomaly. Jane Street's Q1 position in the Bitwise XRP ETF was a mere 20,605 shares. By Q2, it ballooned to 1,200,000+ shares. At an estimated NAV of around $10 per share at the end of June (based on XRP price ~$0.40 and the ETF's structure), that is roughly $12 million in notional exposure. But the growth rate is what matters: 58x in one quarter.
Now, examine the rest of the filing. Wolverine Asset Management, a structured credit and asset management firm, held about 200,000 shares. Gallacher Capital, a hedge fund, held 86,744 shares of the Canary XRP ETF. Bank of America held only 13,260 shares of the Volatility Shares XRP ETF โ worth approximately $76,000. Morgan Stanley's three XRP fund positions totaled around 7,537 shares, a rounding error for a $1.2 trillion asset manager. The Canadian National Bank held 3,848 shares.
Follow the metadata, not the mood. The concentration is extreme. One institution โ Jane Street โ accounts for the vast majority of the disclosed institutional XRP ETF exposure. The other names are either tiny (Bank of America, Morgan Stanley) or modest (Wolverine, Gallacher). This is not a wave of institutional adoption. It is a single whale swimming against a weak current.
The dollar value of Jane Street's position is material, but not massive. $12 million is a rounding error in the context of the $1.3 trillion crypto market. However, the 58x growth rate suggests a deliberate strategy, not a passive rebalancing. Jane Street is a market maker and proprietary trading firm. They are likely using the ETF for arbitrage against the spot XRP market, or to facilitate client flow. They may also be taking a directional bet, but the ETF structure is inefficient for large directional exposure โ the management fee and tracking error eat into returns.
Contrarian: Correlation โ Causation
The narrative that 'institutions are bullish on XRP' is a tempting headline, but it ignores the mechanics. The 13F filings are backward-looking. The price of XRP has declined since June 30, 2025. The ETF's premium or discount to NAV during that period may have presented arbitrage opportunities that are now gone. If Jane Street was simply capturing the spread between the ETF and the underlying XRP, their position could have been fully unwound by now. We will not know until the next 13F filing, due in November.
Furthermore, the presence of Bank of America and Morgan Stanley with sub-$100k positions is not a signal. These are 'check-the-box' allocations โ the minimum required to report and learn. They are not bets. Based on my experience tracking institutional ETF flows at Dune Analytics, I built a pipeline that correlated 13F filings with subsequent price action. The pattern is consistent: small bank positions are statistically insignificant. The only meaningful signal is when a dedicated crypto fund or market maker shows a concentrated position, and even then, the lag kills the edge.
Another blind spot: the ETF structure itself. Spot XRP ETFs hold the actual token, but the custody, audit, and operational costs are passed to investors via management fees. Over time, the ETF's NAV will lag the spot price by the cumulative fee. This is a drag that compounds. For a long-term holder, direct XRP ownership is superior. Therefore, the ETF is primarily a vehicle for (a) tax-advantaged accounts, (b) institutions that cannot hold crypto directly, or (c) arbitrageurs. Jane Street fits category (c).
Takeaway: The Next Signal
The next 13F cycle, due 45 days after the end of Q3 2025, will be the true test. If Jane Street's position is maintained or increased, it suggests a structural shift. If it is reduced or eliminated, the Q2 spike was a one-time arbitrage opportunity. I will be watching the XRP ETF's spread against the spot price, and the AUM growth of the Bitwise fund. The data will speak.
For now, the prudent conclusion is: one large market maker escalated its exposure to an XRP ETF, but the broader institutional footprint remains negligible. The retail narrative is running ahead of the on-chain evidence. Follow the metadata, not the mood. Data doesn't care about your timeline.
